Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo

Journal of Clinical Investigation

Volumn 99, Issue 10, 1997, Pages 2438-2445

  Rensen, Patrick C N ^a   Van Oosten, Marijke ^a   De Van Bilt, Erika ^a   Van Eck, Miranda ^a   Kuiper, Johan ^a   Van Berkel, Theo J C ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

chylomicron; detoxification; emulsion; lipoprotein metabolism; sepsis

Indexed keywords

APOLIPOPROTEIN E; ARGININE; CHYLOMICRON; LIPOFUNDIN; LIPOPOLYSACCHARIDE; RECOMBINANT APOLIPOPROTEIN E; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG MECHANISM; ENDOTOXEMIA; GRAM NEGATIVE BACTERIUM; HYPERTRIGLYCERIDEMIA; HYPOTENSION; KUPFFER CELL; LIPOPROTEIN METABOLISM; LIVER PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0030997483     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119427     Document Type: Article

References (50)

1. Parillo, J.E., moderator. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227-242.
2. Parillo, E.P. 1993. Pathogenic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
3. Freudenberg, M.A., N. Freudenberg, and C. Galanos. 1982. Time course of cellular distribution of endotoxin in liver, lung and kidney of rats. Br. J. Exp. Pathol. 63:56-64.
4. Mathison, J.C., and R.J. Ulevitch. 1979. Clearance, tissue distribution, and cellular localization of iv injected LPS in rabbits. J. Immunol 123:-2133-2143.
5. Ruiter, D.J., J. van der Meulen, A. Brouwer, M.J.R. Hummel, B.J. Mauw, J.C.M. van der Ploeg, and E. Wisse. 1981. Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 45:38-45.
6. Praaning-van Dalen, O.P., A. Brouwer, and D.L. Knook. 1981. Clearance capacity of rat liver Kupffer, endothelial, and parenchymal cells. Gastroenterology. 81:1036-1044.
7. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Wash. DC). 249:1431-1433.
8. Ulevitch, R.J., and P.S. Tobias. 1994. Recognition of endotoxin by cells leading to transmembrane signaling. Curr. Opin. Immunol. 6:125-130.
9. Chensue, S.W., P.D. Terebuh, D.G. Remick, W.E. Scales, and S.L. Kunkel. 1991. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Am. J. Pathol. 138:395-402.
10. Waage, A., P. Brandtzaeg, A. Halstensen. P. Kierulf, and T. Espevik. 1987. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 1, interleukin 6, and fatal outcome. J. Exp. Med. 169:333-338.
11. Feingold, K.R., I. Staprans, R.A. Memon, A.H. Moser, J.K. Shigenaga, W. Doerrler, C.A. Dinarello, and C. Grunfeld. 1992. Endotoxin rapidly induces changes in lipid metabolism that produce hypcrtriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33:1765-1776.
12. Feingold, K.R., and C. Grunfeld. 1987. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Invest. 80:184-190.
13. Wolfe, R.R., J.H.F. Shaw, and M.J. Durkot. 1985. Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. Am. J. Physiol. 248:E732-E740.
14. Kawakami, M., P.M. Pekala, M.D. Lane, and A. Cerami. 1982. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc. Natl. Acad. Sci. USA. 79:912-916.
15. Beutler, B., and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316:379-385.
16. Kaufmann, R.L., C.F. Matson, and W.R. Beisel. 1976. Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. J. Infect. Dis. 133:548-555.
17. Van Lenten, B.J., A.M. Fogelman, M.E. Haberland, and P.A. Edwards. 1986. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl Acad. Sci. USA. 83:2704-2708.
18. Flegel, W.A., M.W. Baumstark, C. Weinstock, A. Berg, and H. Northoff. 1993. Prevention of endotoxin-induced monokine release by human low-and high-density lipoproteins and by apolipoprotein A-I Infect. Immun. 61:5140-5146.
19. Parker, T.S., D.M. Levine, J.C.C. Chang, J. Laxer, C.C. Coffin, and A.L. Rubin. 1995. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63:253-258.
20. Harris, H.W., C. Grunfeld, K.R. Feingold, and J.H. Rapp. 1990. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86:696-702.
21. Harris, H.W., C. Grunfeld, K.R. Feingold, T.E. Read, J.P. Kane, A.L. Jones, E.B. Eichbaum, G.F. Bland, and J.H. Rapp. 1993. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91:1028-1034.
22. Read, T.E., H.W. Harris, C. Grunfeld, K.R. Feingold, M.C. Calhoun, J.P. Kane, and J.H. Rapp. 1993. Chylomicrons enhance endotoxin excretion in bile. Infect. Immun. 61:3496-3502.
23. Rensen, P.C.N., M.C.M. van Dijk, E.C. Havenaar, M.K. Bijsterbosch, and T.J.C. van Berkel. 1995. Selective liver targeting of antivirals by recombinant chylomicrons - a new therapeutic approach to hepatitis B. Nat. Med. 1: 221-225.
24. Vogel, T., K.H. Weisgraber, M.I. Zeevi, H. Ben-Artzi, A.Z. Levanon, S.C. Rall, Jr., T.L. Innerarity, D.Y. Hui, J.M. Taylor, D. Kanner, et al. 1985. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc. Natl. Acad. Sci. USA. 82:8696-8700.
25. Redgrave, T.G., and R.C. Maranhao. 1985. Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim. Biophys. Acta. 835:104-112.
26. Karkhanis, Y.D., J.Y. Zeltner, J.J. Jackson, and D.J. Carlo. 1978. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria. Anal. Biochem. 85:595-601.
27. Van Tol, A., T. van Gent, F.M. van' t Hooft, and F. Vlaspolder. 1978. High density lipoprotein catabolism before and after partial hepatectomy. Atherosclerosis. 29:439-448.
28. McFarlane, A.S. 1958. Efficient trace-labeling of proteins with iodine. Nature (Lond.). 182:53-54.
29. Ulevitch, R.J. 1978. The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. Immunochemistry. 15:157-164.
30. Bijsterhosch, M.K., G.J. Ziere, and T.J.C. van Berkel. 1989. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells. Mol. Pharmacol. 36:484-489.
31. Van Berkel, T.J.C., C.J. Dekker, J.K. Kruijt, and H.G. van Eijk. 1987. The interaction in vivo of transferrin and asialotransferrin with liver cells. Biochem. J. 243:715-722.
32. Blouin, A., R.D. Bolender, and E.R. Weibel. 1977. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma: a stereological study. J. Cell Biol. 72:441-455.
33. Nagelkerke, J.F., K.P. Barto, and T.J.C. van Berkel. 1983. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial. Kupffer and parenchymal cells. J. Biol. Chem. 258:12221-12227.
34. Patthy, L., and E.L. Smith. 1975. Reversible modification of arginine residues; application to sequence studies by restriction of tryptic hydrolysis to lysine residues. J. Biol. Chem. 250:557-564.
35. Rensen, P.C.N., and T.J.C. van Berkel. 1996. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J. Biol. Chem. 271:14791-14799.
36. Van der Poll, T., C.C. Braxton, S.M. Coyle, M.A. Boermeester, J.C.L. Wang, P.M. Jansen, W.J. Montegut, S.E. Calvano, C.E. Hack, and S.F. Lowry. 1995. Effect of hypertriglyceridemia on endotoxin responsiveness in humans. Infect. Immun. 63:3396-3400.
37. Ulevitch, R.J., A.R. Johnston, and D.B. Weinstein. 1979. New function for high density lipoproteins: their participation in intravascular reactions of bacterial lipopolysaccharides. J. Clin. Invest. 64:1516-1524.
38. Wurfel, M.M., S.T. Kunitake, H. Lichenstein, J.P. Kane, and S.D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1025-1035.
39. Munford, R.S., C.L. Hall, and J.M. Dietschy. 1981. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect. Immun. 34:835-843.
40. Levine, D.M., T.S. Parker, T.M. Donnelly, A. Walsh, and A.L. Rubin. 1993. In vivo protection against endotoxin by plasma high-density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:12040-12044.
41. Emancipator, K., G. Csako, and R.J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60:596-601.
42. Huettinger, M., H. Retzek, M. Eder, and H. Goldenberg. 1988. Characteristics of chylomicron remnant uptake into rat liver. Clin. Biochem. 21:87-92.
43. Cohen, M.S., J.H. Mao, G.T. Rasmussen, J.S. Serody, and B.E. Britigan. 1992. Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced Superoxide formation. J. Infect. Dis. 166:1375-1378.
44. Miyazawa, K., C. Mantel, L. Lu, D.C. Morrison, and H.E. Broxmeyer. 1991. Lactoferrin-lipopolysaccharide interactions. Effect of lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J. Immunol. 146:723-729.
45. Machnicki, M., M. Zimecki, and T. Zagulski. 1993. Lactoferrin regulates the release of tumor necrosis factor-α interleukin-6 in vivo. Int. J. Exp. Pathol. 74:433-439.
46. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312:839-845.
47. Rietschel, E.T., H. Gottert, O. Luderitz, and O. Westphal. 1972. Nature and linkages of the fatty acids present in the lipid-A component of salmonella lipopolysaccharides. Eur. J. Biochem. 28:166-173.
48. Appelmelk, B.J., Y.Q. An, M. Geerts, B.G. Thijs, H.A. de Boer, D.M. MacLaren, J. de Graaff, and J.H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628-2632.
49. Morrison, D.C., and D.M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 13:813-818.
50. Park, C.T., and S.D. Wright. 1996. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J. Biol. Chem. 271:18054-18060.